Continuation of anticoagulant and antiplatelet therapy during phacoemulsification cataract surgery

作者：Grzybowski Andrzej^*; Ascaso Francisco J; Kupidura Majewski Konrad; Packer Mark

来源：Current Opinion in Ophthalmology, 2015, 26(1): 28-33.

DOI：10.1097/ICU.0000000000000117

• anticoagulants in ocular surgery
• cataract surgery complications
• ocular surgery complications

Purpose of review
The objective of this review is to evaluate the result of cataract surgery in patients continuing antiplatelet and/or anticoagulant treatment.
Recent findings
The number of elderly patients using anticoagulant and antiplatelet treatment in prevention of venous thromboembolism has significantly increased in recent years. It was believed for many years that those patients might be at higher risk for complications during ocular surgery. Thus, different strategies were proposed to prevent these complications, including discontinuation of anticoagulants, dose reduction, or low-molecular-weight heparin replacement. We performed a PubMed search over a period of 7 years (2007-2013) about possible intraoperative and postoperative complications in patients receiving anticoagulant and/or antiplatelet therapy at the time of cataract surgery. No significant increase in intraoperative or postoperative complications has been identified.
Summary
Phacoemulsification of uncomplicated cataracts with intraocular lens implantation can be performed safely in high-risk patients, taking both anticoagulants and antiplatelet drugs when topical anesthesia is administered and cataract surgery is performed through a clear corneal incision by a skilled surgeon.

• 出版日期2015-1